MEK Inhibitors

MEK inhibitors are a type of medication that targets specific proteins in cancer cells to stop their growth. MEK, short for "mitogen-activated protein kinase," is part of a signaling pathway that helps cells divide and survive. By inhibiting MEK, these drugs can slow down or halt the progression of certain cancers, particularly those driven by genetic mutations. They're often used in targeted cancer therapies and can be combined with other treatments to enhance effectiveness. While promising, they can also have side effects, and their use is typically based on specific cancer types and patient conditions.